In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin.
The in vitro activity of BMY-28142 was compared with that of cefotaxime, ceftazidime, moxalactam, and imipenem against 639 clinical isolates and a number of in vitro-selected resistant mutants. BMY-28142 was the most potent compound against the members of the family Enterobacteriaceae with a MIC for...
Сохранить в:
| Опубликовано в:: | Antimicrob Agents Chemother |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology (ASM)
1985
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180098/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3859244/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.4.574 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|